Lataa...
Minimal Residual Disease in Acute Myeloid Leukemia
Technological advances in the laboratory have lead to substantial improvements in clinical decision-making by the use of pre-treatment prognostic risk stratification factors in acute myeloid leukemia (AML). Unfortunately similar progress has not been made in treatment response criteria, with the def...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4163748/ https://ncbi.nlm.nih.gov/pubmed/23799371 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2013.100 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|